Featured Research

from universities, journals, and other organizations

Nearly 50 percent of physicians believe diversion of ADHD stimulant medications among teens is a problem

Date:
May 3, 2014
Source:
North Shore-Long Island Jewish (LIJ) Health System
Summary:
Two recent studies examined physicians' perceptions and knowledge of diversion of stimulant medications for Attention Deficit Hyperactivity Disorder as well as practices physicians use to prevent diversion among their patients prescribed these medications.

Two recent studies by investigators at the Cohen Children's Medical Center of New York examined physicians' perceptions and knowledge of diversion of stimulant medications for Attention Deficit Hyperactivity Disorder (ADHD) as well as practices physicians use to prevent diversion among their patients prescribed these medications.

Related Articles


The results showed that while almost half of all physicians surveyed believe diversion is common among teens with ADHD, the majority never received training on the topic. Furthermore, about one-third of physicians rarely counsel teens about the health and legal consequences of diverting stimulating medication and don't feel qualified to do so.

"Diversion of stimulation medications for ADHD by high school and college students is widespread as those with ADHD are often sharing pills with their peers, who don't have the condition, to try to improve their academic performance," said Andrew Adesman, MD, senior investigator and chief of developmental behavioral pediatrics at Cohen Children's Medical Center of New York. "Many pediatric colleagues don't feel adequate in counseling their ADHD patients about diverting stimulant medications or are unfamiliar with some of the legal and health consequences of non-ADHD patients taking an unprescribed controlled substance." The survey analyzed responses from 815 physicians who specialize in ADHD -- child neurologists, child psychiatrists and developmental pediatricians. In the past 12 months, 59 percent of physicians suspected some of their teen ADHD patients were diverting their medications and 54 percent believed some patients were exaggerating symptoms to obtain stimulation medications to divert. When evaluating teens for an initial diagnosis of ADHD, 66 percent of doctors suspected that some patients were trying to obtain stimulant medication to improve academic performance. Surveyed doctors also believed patients wanted the medication to either lose weight (40 percent), get high (38 percent) or divert their stimulant medication to others (39 percent).

The study also showed that the majority of physicians received no training on prevention of prescription drug diversion in medical school (73 percent), residency (57 percent) or fellowship (51 percent).

When physicians were asked if there is a difference in the legal consequence of selling vs. giving away stimulant medication, 19 percent chose the wrong answer and 36 percent were unsure.

Dr. Adesman said that "in the eyes of the law, there is no difference between someone giving away a pill or selling one; they are both prosecuted as unlawful distribution of a controlled substance."

As far as health risks, he also noted that, "A patient taking an ADHD medication has been titrated up to a certain dose over time. If someone else takes another person's dose it can be risky because there is no health history and medication naiveté can lead to potential risks, especially if there is an underlying heart condition.

"While many prevention strategies can be used to prevent diversion of stimulant medication- informational brochures, a medication contract, pill counts, limiting pill quantities, counseling and other methods, our research showed that while doctors are encouraged to use many of these strategies, most MDs don't believe the strategies to be effective," Dr. Adesman said. "It is important that physicians treating patients with ADHD are continually educated about stimulant diversion problems and become active in mitigating this from happening."


Story Source:

The above story is based on materials provided by North Shore-Long Island Jewish (LIJ) Health System. Note: Materials may be edited for content and length.


Cite This Page:

North Shore-Long Island Jewish (LIJ) Health System. "Nearly 50 percent of physicians believe diversion of ADHD stimulant medications among teens is a problem." ScienceDaily. ScienceDaily, 3 May 2014. <www.sciencedaily.com/releases/2014/05/140503082741.htm>.
North Shore-Long Island Jewish (LIJ) Health System. (2014, May 3). Nearly 50 percent of physicians believe diversion of ADHD stimulant medications among teens is a problem. ScienceDaily. Retrieved March 5, 2015 from www.sciencedaily.com/releases/2014/05/140503082741.htm
North Shore-Long Island Jewish (LIJ) Health System. "Nearly 50 percent of physicians believe diversion of ADHD stimulant medications among teens is a problem." ScienceDaily. www.sciencedaily.com/releases/2014/05/140503082741.htm (accessed March 5, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, March 5, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) — Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) — Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) — AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Adults Only Get The Flu Twice A Decade, Researchers Say

Adults Only Get The Flu Twice A Decade, Researchers Say

Newsy (Mar. 4, 2015) — Researchers found adults only get the flu about once every five years. Scientists analyzed how a person&apos;s immunity builds up over time as well. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins